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Leprosy is a chronic disease resulting from symptomatic infection with Myco-
bacterium leprae, which currently affects nearly 12 million persons worldwide (1) .
Although most prevalent in tropical areas, indigenous cases continue to occur in
the United States (2). Leprosy is currently regarded as representing a spectrum
of disease states in which the host response to the organism governs clinical
manifestations . At one end of the spectrum is tuberculoid leprosy, in which skin
lesions are paucibacillary and parameters of cell-mediated immunity (CMI)' are
intact, and at the opposite end is lepromatous leprosy, in which macrophages
and Schwann cells in skin lesions are packed with viable bacilli andM . leprae-
specific CMI is poor .
Recently a phenolic glycolipid, PGL-1, unique toM . leprae, was isolated and
characterized (3, 4) . PGL-1 contain an antigenically distinct trisaccharide con-
sisting of 3,6-di-O-methyl-glucose-linked al --+ 4 to 2,3-di-O-methyl-rhamnose-
linked /31 --* 2 to 3-0-methyl rhamnose . This trisaccharide portion is glycosidically
linked to a phenol that is linked to a 29-carbon phthiocerol to which are attached
two tetra-methyl branched mycoserosic acids. Lesser amounts of phenolic gly-
colipid II, which contains 3-0-methyl rhamnose rather than 2,3-di-O-methyl
rhamnose as the middle sugar, and phenolic glycolipid III, which contains 6-0-
methyl glucose rather than 3,6-di-O-methyl glucose as the terminal sugar, also
are present. PGL-I is present in large amounts, up to 2% of the mass of the
bacilli (3), and antibodies directed against it are detected in the sera of affected
individuals (4-6) . These antibodies are predominantly of the IgM class (7) and
increase along the leprosy spectrum, with the highest titers in lepromatous cases
(7) . Antigenic specificity resides in the terminal sugars, and artificial antigens
have been synthesized containing the terminal sugars for use in serodiagnosis
and evaluation of cases of leprosy (8, 9) . PGL-1 has also been directly detected
in the sera and urine of leprosy patients (10, 11) . It has been suggested that
PGL-1 may function as part of a lipid capsule surrounding the organism which
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' Abbreviations used in this paper:
￿
CMI, cell-mediated immunity ; dPGL, deacylated phenolic
glycolipid-1 ; EPO, eosinophil peroxidase ; H202, hydrogen peroxide ; MPO, myeloperoxidase ; '02,
singlet oxygen ; 02, superoxide anion ; OH , hydroxyl radical; PD, calcium-and magnesium-free PBS ;
PGL-1, phenolic glycolipid-1 ; SOD, superoxide dismutase ; XO, xanthine oxidase .
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protects it from the host environment (12, 13). We posed the question: does the
PGL-1 surrounding the M. leprae scavenge the toxic oxygen metabolites formed
by macrophages and in this way allow the organisms to survive and replicate?
Phagocytes contain a variety ofantimicrobial systems, some which are depend-
ent on oxygen and others which are not. The oxygen-dependent antimicrobial
systems use toxic oxygen metabolites formed by the phagocytosis-induced respi-
ratory burst (14). These include the superoxide anion (0- 2 *), hydrogen peroxide
(H202), hydroxyl radical (OH'), and possibly singlet oxygen ('02), with the
toxicity of H202 being greatly potentiated by peroxidase (myeloperoxidase
[MPO], eosinophil peroxidase [EPO]) and a halide. MPO ispresentin cytoplasmic
granules of neutrophils and monocytes and is released into the phagosome after
particle ingestion. When monocytes transform into macrophages, either in vitro
or in vivo, their granule peroxidaseis lost. In addition, there is amarked decrease
in the respiratory burst and in part as a result, the microbicidal potency of the
cells is decreased and certain pathogens can survive and replicate intracellularly.
Activation of macrophages by IFN-y potentiates their microbicidal activity due
in part to an increase in the respiratory burst.
The xanthine oxidase (XO) system has been used as a model of the oxygen-
dependent antimicrobial systems of phagocytes (15, 16). In the course of the
oxidation ofits substrate (xanthine, hypoxanthine, or acetaldehyde), XO reduces
oxygen to 02, H202 is formed either directly from oxygen or by dismutation of
02, and the 02 and H202 interact in an iron-catalyzed reaction to form OH' as
follows: 02 + H202 F-7 02 + OH- + OH' (Haber-Weiss reaction). When a
reaction initiated by the XO system is inhibited by catalase which degrades H202,
superoxide dismutase which scavenges 02, and by OH' scavengers such as
mannitol or ethanol, this has been taken as presumptive evidence for the
involvement of OH' (or a closely related species) generated by the Haber-Weiss
reaction.
In this study we have examined the role of PGL-1 in the protection of M.
leprae from the antimicrobial systems of human mononuclear phagocytes. Be-
causestudies ofthe susceptibility ofM. leprae to the various antimicrobial systems
of phagocytes, both in cell-free form and in intact cells, are complicated by the
inability to grow the organism in vitro, thus making measurement of viability
difficult, we have used fast-growing Staphylococcus aureus as the test organism.
The staphylococci were exposed to the cell-free MPO and XO systems and to
human monocyte-derived macrophages either untreated or activated by IFN-'y
and the effect of the purified PGL-1 on viability was determined. The PGL-1
was either added as such or bound to the surface of the staphylococci by an
immunologic technique. We found that PGL-1 is a weak scavenger of the toxic
products of the peroxidase-H202-halide system and that it prevents bacterial
killing by OH' generated by the XO system and by IFN-y-activated macro-
phages. These results suggest a role for PGL-1 in the intracellular persistence of
M. leprae in certain cell types.
Materials and Methods
Special Reagents.
￿
Histopaque 1077 was obtained from Sigma Chemical Co. (St. Louis,
MO), sodium chloride (Suprapur) was obtained from Matheson-Coleman-Bell Manufac-3 2
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turing (Cincinnati, OH), and superoxide dismutase (SOD) was obtained from Miles
Scientific Div. (Naperville, IL). RPMI 1640 was supplemented with Hepes buffer (10
MM), L-glutamine (0.2 mM), penicillin (25 U/ml), and streptomycin (25 kg/ml); all
components were obtained from Whittaker M . A. Bioproducts (Walkersville, MD). Au-
tologous or AB serum was prepared by allowing whole blood to clot for 30-60 min at
room temperature, and the supernatant was collected after centrifugation and frozen at
-70°C until use. MPO was purified from canine pyometrial pus by the method of Agner
(17) to the end of step 6, and assayed by guaiacol oxidation (18). XO obtained from
Boehringer Mannheim Biochemicals (Indianapolis, IN), and catalase, obtained from
Worthington Biochemical Corp. (Malvern, PA), were dialyzed against sterile nonpyrogenic
water before use. Rabbit anti-mouse IgM and FITC-conjugated F(ab')z goat anti-rabbit
IgG were obtained from Zymed Laboratories (San Francisco, CA) and FITC F(ab')z goat
anti-mouse IgM was obtained from Tago Inc. (Burlingame, CA). Purified PGL and its
deacylated derivative (dPGL) were kindly provided by P. Brennan, Colorado State
University (Fort Collins, CO). mAb B8F (12) directed against the terminal glycoside
moiety of PGL-1 was from T . Buchanan and R. Miller, University of Washington (Seattle,
WA) and the human rIFN-y was from P. Trown, Hoffman-La Roche (Nutley, NJ). IFN-
y activity was determined by the supplier in a WISH/VZV cytopathic effect microtiter
assay standardized with NIH human IFN-y (reference standard Gg 23-901-530). The
502A and Cowan strains of S. aureus, kindly provided by R. E. Bryant, Oregon Health
Sciences University (Portland, OR), were maintained on blood agar plates and grown at
37°C in trypticase soy broth (Baltimore Biological Laboratories, Cockeysville, MD) for
the periods indicated.
Glassware was heated at 1700 C for 24 h to destroy endotoxin. All media and buffers
were prepared in sterile pyrogen-free water from Travenol Laboratories Inc. (Deerfield,
IL) and were filtered before use with 0.22-tan filter units from Corning Glass Works
(Corning, NY).
Preparation ofPhenolic Glycolipid.
￿
Known amounts of PGL-1 and dPGL were dissolved
in a mixture of chloroform/methanol 2:1 [vol/vol] and aliquots were blown to dryness
under nitrogen in glass tubes. Suspensions of PGL-1 and dPGL were made by sonicating
the lipids in either pyrogen-free water or PBS for two 30-s bursts at setting 6 of a model
200 Sonifier (Branson Sonic Power Co., Danbury CT). Lipid suspensions were kept at
37°C until use.
Microbicidal Activity.
￿
The components indicated in the legends to Tables I and 11 were
incubated in 12 X 75-mm plastic tubes in a shaking water bath oscillating 80 times/min.
At the times indicated, 0.1-ml aliquots were removed, serially diluted in 0.1 M sodium
sulfate, and the viable cell count was determined by the pour-plate method using trypticase
soy agar. The absence of colonies on plating 0 .1 ml of the undiluted incubation mixture
is designated 0 organisms/ml (actually <10).
Preparation ofPGL-coated Staphylococci.
￿
The Cowan strain ofS. aureus, which is known
to be rich in protein A, was grown to mid-log phase for 4 h at 37 ° C in trypticase soy
broth . After three washes in PBS with 1 % BSA, the bacteria were resuspended to an OD
of 0.18 at 540 nm (model M15 spectrophotometer; Cary Instruments, Monrovia, CA)
and then 1 ml of this suspension was incubated with rabbit IgG anti-mouse IgM for 30
min in a shaking water bath at 37°C. The bacteria were then washed twice to remove
unbound antibody. The staphylococci, bearing rabbit anti-mouse IgM bound to surface
protein A, next were incubated with the IgM murine mAb B8F for 30 min in a shaking
water bath at 37'C. The bacteria were washed twice to remove unbound antibody,
resuspended, and divided into two equal aliquots. Aliquot A was incubated with PBS and
aliquot B was incubated at 37°C in a shaking water bath with a suspension of dPGL at I
mg/ml.
Chromatography.
￿
HPLC of dPGL was performed as described (10) using a ttPorasil
Column (0.39 X 30-cm, 10 gm), an automated gradient controller with model 501 HPLC
pump, an automatic injector (model 710B), a data module (model 740) and a Lambda-
Max spectrophotometer (model 481 LC) (Waters Associates, Milford, MA). The eluant
was 4% methanol in chloroform at a flow rate of 1 ml/min.NEILL AND KLEBANOFF
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Monocyte Culture.
￿
Venous blood was obtained after informed consent from healthy
human volunteers and the monocytes were isolated as previously described (19). Briefly,
after two washes with cold calcium- and magnesium-free PBS (PD), the cell suspension
was underlayered with Histopaque 1077 and centrifuged at 800 g for 20 min at 23°C.
Mononuclear cells, after removal from the PD-Histopaque interface, were washed twice
in PD and resuspended in RPMI 1640 with 15% autologous or AB serum. Monocytes
were added to 35-mm-diam tissue culture plates (Primaria type; Falcon Labware, Becton,
Dickinson & Co., Oxnard CA) in 2-ml vol containing 2.5-3.0 million monocytes and
incubated for 2 h at 37°C in humidified 5% C02/95% air. Plates were then washed six
to eight times with warm PBS to remove nonadherent cells, 2 ml of fresh media were
added to each plate, and monolayers were maintained at 37'C in humidified5% C02/95%
air. Monolayers supplemented with IFN-y had fresh medium containing 200 U/ml of the
cytokine added on days 1-3. Control monolayers had fresh medium alone added at similar
times .
On day 4, control monolayers and those supplemented with IFN-'r were washed four
to six times with warm HBSS. Reaction mixtures of antibody-coated staphylococci either
with or without dPGL were added to macrophage monolayers. The tissue culture plates
were centrifuged at 250 g for 2 min at room temperature and then incubated for 3 min
at 37 ° C in humidified 5% C02/95% air. The reaction mixtures were then removed and
the monolayers washed twice with HBSS. To determine the number of cell-associated
bacteria at this time point (designated To), monolayers were incubated in water for 5-10
min, scraped with a sterile transfer pipette to lyse the cells, and the number of viable
bacteria enumerated by a pour-plate method using trypticase soy agar. Remaining mon-
olayers were incubated in RPMI 1640 with 15% AB serum without added antibiotics for
90 min in humidified 5% C02/95% air. To determine the number of surviving bacteria
at this time point (designated Tso), the reaction mixtures were removed and the monolay-
ers lysed as described above. Lysostaphin was not used because of evidence suggesting its
uptake by phagocytes (20).
Electron Microscopy.
￿
Incubation of staphylococci with the mononuclear phagocytes was
carried out as described above except that monolayers were fixed rather than lysed at the
designated time points. Cells were fixed for 60 min in half-strength Karnovsky's fixative
(21) and then washed twice with 0.1 M cacodylate buffer. Fixed monolayers were
dehydrated with increasing concentrations of ethanol and gradually infiltrated with
Poly/Bed 812 (Polysciences, Inc., Warrington, PA). Thin sections were stained with
uranyl acetate and lead citrate, and examined with a Phillips 410 transmission electron
microscope (Phillips Electronic Instruments, Inc ., Mahwah, NJ).
Results
Effect of PGL-1 and dPGL on the Bactericidal Activity of the Peroxidase Sys-
tem. The effect of PGL-1 and dPGL on the microbicidal activity of the MPO-
H202-halide system is shown in Table I. Two experimental conditions were
used . In system A, the H202 concentration was 10-4 M and the halide was either
10' M chloride or 10-4 M iodide . Under these conditions, the complete system
produced a >3-log fall in viable cell count after a 30-min incubation whereas
none of the individual components of the system was toxic. The addition of
either PGL or dPGL at a concentration of 100 wg/ml had no effect on the
bactericidal activity of the peroxidase system under these conditions (Table I).
The lipids also were ineffective when preincubated with the bacteria for 15 min
before the addition of the components of the complete system. Neither lipid was
toxic at these concentrations when incubated with the bacteria alone. The
concentrations of H202 and the individual halides were decreased to the lowest
levels at which a >2-log fall in viable organisms were consistently observed after
a 30-min incubation and these conditions (2 .5 x 10-6 M H202 , 10-2 M chloride,34
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TABLE I
Effect ofM. leprae Phenolic Glycolipid on theMPO-H202-Halide System
Both systems A and B contained 0.01 M sodium phosphate buffer (pH 7.0), 0.067 M sodium
sulfate, 5 X 106 S. aureus 502a, and 225 mU/ml MPO. System A contained 10-' M H202 and
where indicated 10' M NaCl or 10' M Nal. System B contained 2.5 X 10-6 M H202 and where
indicated 10-2 M NaCl or 5 X 10-6 M NaI. Final volumes, 0.5 ml. Incubations were carried outat
37'C for 30 min.
Significance (p) vs. complete system A.
$Significance (p) vs. complete system B.
Mean of (n) experiments.
or 5 X 10` M iodide) were designated system B. The addition of PGL and
dPGL completely blocked the microbicidal effect of system B with chloride as
the halide but did not completely prevent killing when iodide was used (Table
I).
Effect of PGL-1 and dPGL on the Bactericidal Activity of XO System.
￿
The
incubation ofacetaldehyde, XO, and Fe21 with S. aureus produced a >2-log fall
in the viable cell count after a 30-min incubation under the conditions used in
Table II. As previously reported (15, 16), this microbicidal effect was abolished
by SOD, catalase, mannitol, or ethanol, but not by heat-inactivated SOD or
catalase, thus implicating OH' generated by the Haber-Weiss reaction. The
addition of 100 kg/ml of PGL-1 or dPGL to the reaction mixture completely
abolished the antimicrobial effect suggesting that the lipid can scavenge OH'
generated by the XO system. The addition of either glycolipid had no effect on
the activity ofXO as measured by xanthine oxidation.
BindingofdPGL to S. aureus.
￿
A "surrogate M. leprae" wasprepared by binding
the phenolic glycolipid ofM. leprae to the surface ofS. aureus through the use
of linking antibodies. The Cowan strain ofS. aureus is rich in protein A which
binds to the Fc region of IgG molecules. Because the murine mAb B8F, which
is specific for the terminal trisaccharide of PGL-1, is an IgM, an antibody class
that does not bind staphylococcal protein A, and IgG antibody directed against
murine IgM was used to bind the PGL-1-IgM complex to surface protein A.
The optimum conditions for antibody binding were established by fluorescence
microscopy ofbacteria coated with rabbit IgG anti-mouse IgM and subsequently
stained with FITC-conjugated F(ab')2 goat anti-rabbit IgG. No staining of
uncoated bacteria occurred and maximum fluorescence was observed on incu-
bation of the staphylococci with a 1 :50 dilution of the rabbit IgG anti-mouse
IgM. Optimum conditions were similarly established for binding ofthe monoclo-
nal IgM antibody to the IgG-coated staphylococci by fluorescence microscopy of
Supplements
System A
Viable cell
p
.
count
System B
None 3.55 (3)§
cfu X 10-6/ml
<0.001 3.52 (4) <0.001
MPO + H202 + Cl- 0.001 (3) - 0.02 (3) -
+PGL (100 Pg/ml) 0.00003(3) NS 3.60 (2) <0.001
+ dPGL (100 kg/ml) 0.00001 (3) NS 4.13 (2) <0.001
MPO + H202 + 1- 0.00008 (3) NS 0.002 (3) NS
+ PGL (100 wg/ml) 0.00006(3) NS 0.06 (3) NS
+dPGL(100,ug/ml) 0.00005(3) NS 0.03 (3) NSNEILL AND KLEBANOFF
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TABLE lI
Effect ofM. leprae Phenolic Glycolipid on the
Xanthine Oxidase System
The reaction mixture contained 0.01 M sodium phosphate buffer (pH
7.0), 0.067 M sodium sulfate, 5 x 106 S. aureus 502a, 1.4 x 10-' M
acetaldehyde, 30 ug xanthine oxidase, and 10-6 Mferroussulfate. Where
indicated, the SOD wasautoclaved at 120°C for 30 minand thecatalase
was heated at 100°C for 15 min.
' Significance (p) vs. complete system.
$Mean of (n) experiments.
IgM-IgG-coated bacteria stained with FITC-conjugated F(ab')2 goatanti-mouse
IgM. Maximum binding ofIgM anti-PGL-1 mAb occurred at a dilution of 1 :50.
The fluorescence with both antibodies was evenly distributed on all of the
organisms. Staphylococci with surface-bound IgG-IgM were then incubated with
dPGL. To determine that dPGL was bound to the staphylococci, bound lipid
was extracted and dPGL demonstrated by HPLC. After washing four times,
bacteria were extracted with chloroform/methanol (2:1 [vol/vol]), and the chlo-
roform layer was removed and evaporated to dryness under nitrogen. Samples
were taken up in 4% methanol in chloroform and subjected to HPLC. Repre-
sentative chromatographs are shown in Fig. 1. HPLC of the chloro-
form/methanol extract of dPGL-coated staphylococci (Fig. 1 B) yielded a com-
pound with a retention time identical to that of authentic dPGL standard (Fig.
1 A) (n = 3). The standard and extracted lipidboth had equal changes in retention
time when rechromatographed using a different solvent system (chloroform with
3% methanol) (data not shown). No dPGL peak was observed by HPLC of a
chloroform/methanol extract of control staphylococci coated with the IgG and
IgM antibodies but not with dPGL (Fig. 1 C).
Effect of dPGL on the Antimicrobial Activity of Monocyte-derived Macro-
phages. Human blood monocytes were maintained as adherent monolayer cul-
tures for 4 d with the culture medium supplemented with 200 U/ml of IFN-y
for the final 3 d in halfofthe cultures. When nonactivated macrophages (without
IFN-y treatment) were exposed to staphylococci coated with the IgG and IgM
antibodies, but without PGL for 90 min, 9% ofthe cell-associated bacteria were
killed (Table III). Activation ofthe macrophages with IFN-y for 3 d resulted in
a marked increase in antimicrobial activity with 74% of cell-associated bacteria
Supplements Viable cell
count
cfu x 10-6/ml
p
.
None 4.49 (9)* <0.001
Acet + XO + Fe" 0.014 (9) -
+ SOD (5 ug/ml) 4.39 (7) <0.001
+ heated SOD (5 ug/ml) 0.054 (5) NS
+ catalase (60 ag/ml) 5.96 (8) <0.001
+ heated catalase (60 ug/ml) 0.032 (4) NS
+ mannitol (10' M) 2.60 (6) <0.001
+ ethanol(10' M) 3.16 (6) <0.001
+ PGL (100 ug/ml) 3.52 (3) <0.001
+ dPGL (100 ug/ml) 3.48 (3) <0.00136
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FIGURE 1 . HPLC of (A) pure dPGL standard; (B) chloro-
form/methanol extraction of staphylococcicoated with dPGL, and
IgG and IgM antibodies; (C) chloroform/methanol extraction of
control staphylococci coated with antibodies alone. HPLC condi-
tions are described under Materials and Methods. Arrow denotes
elution of void volume.
killed at the end of the 90-min incubation period. When dPGL-coated staphylo-
cocci were used, not only was killing by both the control and IFN-y-supple-
mented macrophages completely blocked but these log-phase organisms contin-
ued to replicate, resulting in an 84 and 39% increase in the viable cell count at
the end of the 90 min (Table III).
Electron Microscopy. Nonactivated and IFN-y-activated human monocyte-
derived macrophages incubated with S. aureus with or without dPGL on their
surface were examined by transmission EM. The findings with IFN-y-treated
macrophages are shown in Fig. 2. Macrophages, incubated either with staphylo-
cocci coated with the IgG and IgM antibodies but without dPGL (Fig. 2a), or
with staphylococci coated with antibodies and dPGL (Fig. 2b), contained intra-
phagosomal organisms, indicating that coating with dPGL does not prevent
phagocytosis by human monocyte-derived macrophages. Several of the staphy-
lococci are dividing, which reflects the use of log-phase organisms for theseNEILL AND KLEBANOFF
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TABLE III
Effect ofPGL-1 on S. aureus Phagocytosed by Human
Monocyte-derived Macrophages
Presence of dPGL on
S. aureus
Percent change in viable S. aureus
Macrophage monolayers
-IFN
￿
+IFN
-dPGL
￿
-9 (3)*
￿
-74(3)
+dPGL +84(3) +39(3)
Human blood monocytes were maintained as adherent monolayers for
4 d with some of the monolayers supplemented with 200 UJml IFN-'y
on days 1-4. Monolayers were exposedto log-phasestaphylococcicoated
with either IgG and IgM antibodies alone or with both antibodies plus
dPGL. The number of viable bacteria was determined afterlysis of the
monolayer at the beginning and end of the 90 min incubation period,
and the percentchange in viable bacteria calculated.
* Mean of (n) experiments.
studies. The findings were similar when nonactivated monocyte-derived macro-
phages were used.
Discussion
We report that the major glycolipid antigen of M. leprae, PGL-1, and its
deacylated derivative, can scavenge the reactive oxygen species generated by
stimulated phagocytes, and that this may protect the organism from the antimi-
crobial activity of activated human macrophages. These conclusions are based
on the following lines of evidence.
First, both PGL-I and dPGL abolished the antimicrobial effect of the acetal-
dehyde-XO-Fez+ system on S. aureus. This system generates 02, H202,
and OH', all of which may be produced by stimulated phagocytes and thus has
been used as a model for the oxygen-dependent antimicrobial systems of these
cells (15, 16). That the observed cytotoxicity of the XO system is due to OH'
(or an oxidant with similar properties) generated by the Haber-Weiss reaction,
is suggested by the inhibition of toxicity by catalase (which degrades H202) and
SOD (which scavenges 02) but not by heated catalase or SOD, and by the OH'
scavengers, mannitol and ethanol. These findings suggest that PGL-I (or dPGL)
can act as an OH' scavenger and thus protect the target organism from the
harmful effects of this toxic oxygen species.
Second, both PGL-1 and dPGL exhibited a modest protective effect against
the cytotoxicity of the peroxidase-H202-halide system. When the individual
components of the MPO system were titrated to produce at least a 2-log decrease
in the viable cell count, both PGL-1 and dPGL, at the concentrations used,
completely inhibited toxicity with chloride, but not iodide, as the halide. It is
possible that higher concentrations of the glycolipids would completely inhibit
peroxidase-mediated toxicity with both halides. In patients with leprosy, large
numbers of acid-fast bacilli have been detected in circulating polymorphonuclear
leukocytes and monocytes (22), both of which contain myeloperoxidase in cyto-
plasinic granules. Presumably a proportion of these bacilli areviable, as organisms38
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recovered from blood in bacteremic leprosy patients have been shown to be
infective in the mouse footpad (23). It is possible that when large amounts ofthe
glycolipid are present, as in heavily parasitized blood phagocytes, PGL-1 may
prevent peroxidase-mediated toxicity.
Lastly, dPGL prevented killing of staphylococci by human monocyte-derived
macrophages activated by IFN-y. The dPGL was bound to the surface of the
staphylococci by a double-antibody technique using a specific IgM mAb directed
against the trisaccharide portion of PGL-1, and an IgG anti-IgM antibody which
bound both to the PGL-1-IgM complex via its antibody combining site and to
the staphylococci via the interaction of its Fc portion with the protein A of the
organism . Human blood monocytes, when maintained as adherent monolayers,
undergo striking biochemical and morphologic changesas they differentiate into
macrophages, among which are the loss of granule peroxidase (24-26) and a
marked decrease in their respiratory burst in response to stimulation (26).
Supplementation of the culture medium with IFN-y results in activation of the
macrophages as indicated by a marked increase in respiratory burst (27), anti-
microbial (28, 29), and antiparasitic(30, 31)activities. Human monocyte-derived
macrophages demonstrated considerably greater staphylocidal activity when
cultured with IFN--y. The presence of the M. leprae-derived glycolipid on the
surface of the staphylococci prevented killing by the IFN-y-activated macro-
phages, despite the presence of the microorganisms in phagosomes.
The mechanisms by which M. leprae survive and replicate in phagocytes are
not well understood . The organisms are readily killed by the cell-free MPO-
H202 system (32) although it is not known whether this system is effective in
intact neutrophils or monocytes. Exposure of M. leprae to 0.08% H202 resulted
in a marked loss ofviability, asjudged by loss ofinfectivity in the mouse footpad
(33). The failure of M. leprae to induce a respiratory burst, as measured by 02
production in murine (BALB/c)peritoneal macrophages, or in human peripheral
blood neutrophils or monocytes has been reported (34), and M. leprae contains
SOD (35, 36) which may protect the organisms by scavenging 02.
It has been suggested that PGL-1, being a surface component, may form a
capsule around M. leprae (13). The presence ofa capsule in certain microorga-
nisms may be a mechanism for avoidance of host-defense systems by preventing
phagocytosis (37). However, PGL-1 does not appear to be antiphagocytic as both
M. leprae (38) and dPGL-coated staphylococci are ingested by human macro-
phages. Evidence has been presented here suggesting that a key contribution of
PGL-1 tothe intracellular survival ofM. leprae may bethe ability oftheglycolipid
to scavenge reactive oxygen species and thereby prevent microbial death within
the phagosome.
Summary
Purified PGL-1 and dPGL from M. leprae can prevent bacterial killing by
intact phagocytesand cell-free antimicrobial systems. Both glycolipids completely
abolishedthe antimicrobial effect ofthe acetaldehyde-XO-Fe21 system. Because
the cytotoxicity of this system is inhibited by catalase, SOD, mannitol, and
ethanol, but not by heated SOD or catalase, these data suggest that toxicity is
due to OH' generated by the Haber-Weiss reaction . That the antimicrobial40
￿
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killing in the XO system is completely blocked by the addition of PGL-1 or
dPGL suggests that these glycolipids can act as OR scavengers. A modest
protective effect against the cytotoxicity of the MPO-H202-halide system by
both PGL-1 and dPGL was also observed. The antimicrobial activity of the MPO
system was abolished with chloride, but not iodide, as the halide. The effect of
the M. leprae-derived glycolipid on bacterial killing by intact phagocytes was
examined. Two linking antibodies were used to bind the dPGL to a rapidly
growing test organism, S. aureus, a murine IgM mAb specific for the terminal
glycoside of PGL-l, and a rabbit IgG anti-mouse IgM which bound the staphy-
lococcal protein A via its Fc region. Examination by transmission EM of human
monocyte-derived macrophages which had ingested staphylococci either coated
with both antibodies and dPGL, or coated only with the IgG and IgM antibodies,
demonstrated the presence of bacteria in phagosomes of control and IFN-7-
activated macrophages. Activation of the macrophage monolayers by pretreat-
ment with IFN-7 markedly increased their staphylocidal activity. When dPGL
coated staphylococci were ingested, killing by both control and IFN-'y-activated
macrophages was completely blocked. These results, suggesting that PGL-1 can
scavenge reactive oxygen species and prevent microbial death within the phag-
osome, may in part explain the intracellular survival of M. leprae in certain cell
types.
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